Loading fund overlap…
12 of 134 unique stocks in common · Jaccard: 9%
A weighted portfolio overlap of 12.61% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹12.61 is allocated to the exact same companies at the same relative proportions. The schemes share 12 common holdings.
The largest overlapping asset in their portfolios is Reliance Industries, which commands a weight of 3.56% in Aditya Birla Sun Life Value Fund and 8.46% in Tata Nifty500 Multicap India Manufacturing 50-30-20 Index Fund. Holding both schemes increases your concentration in Reliance Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Aditya | in Tata |
|---|---|---|
| Reliance IndustriesPetroleum Products | 3.56% | 8.46% |
| Bharat Heavy ElectricalsElectrical Equipment | 2.05% | 1.89% |
| Tube Investments of IndiaAuto Components | 1.64% | 1.04% |
| Hero MotoCorpAutomobiles | 1.00% | 1.98% |
| Welspun CorpIndustrial Products | 3.61% | 0.86% |
| Bharat ElectronicsAerospace & Defense | 0.85% | 3.12% |
| PI IndustriesFertilizers & Agrochemicals | 0.81% | 0.70% |
| AstralIndustrial Products | 1.06% | 0.60% |
| Carborundum UniversalIndustrial Products | 0.90% | 0.57% |
| Granules IndiaPharmaceuticals & Biotechnology | 1.54% | 0.53% |
| Asahi India GlassAuto Components | 0.80% | 0.52% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 0.48% | 4.04% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.